Director Kathy Palmer Ordonez proposes selling 18,595 Pacific Biosciences (PACB) shares.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Pacific Biosciences of California (PACB) director Kathy Palmer Ordonez has filed a Form 144, proposing to sell 18,595 common shares with an approximate sale date of November 17, 2026, and an aggregate market value of $33,093.52. The shares were acquired through restricted stock vesting in February 2022 for services rendered.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.